A shadow market for unapproved weight-loss drugs is being driven by social media fitness personalities and sellers on communication apps, according to recent findings.
Experimental Drug Gaining Popularity Online
Retatrutide, which is still in research studies, is being promoted by social media influencers for its supposed fat-burning effects. Viewers are urged to message these profiles directly for source information, while also receiving promotional offers.
Thriving Trade on Social Networks
Separately, a robust trade exists on messaging services, where groups with numerous of members share “before and after” images, injection guides and claims of rapid UK delivery. Sellers promote the substance there before directing customers to WhatsApp for transactions.
Understanding The Experimental Drug
This medication is an experimental injectable created by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – GLP-1, GIP and glucagon. Preliminary studies suggest it could assist patients reduce up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being hailed online as the successor to Ozempic.
Healthcare Professionals Voice Concerns
Nevertheless, doctors and pharmacists have warned that the sale of what remains an unlicensed medication in the UK is a cause for concern and could result in users injecting substances of unknown origin.
Several professionals stated the demand for the experimental drug could be connected to the increasing cost of approved weight loss products such as Mounjaro.
Legal Status and Enforcement
Selling retatrutide on social media or Telegram is prohibited in the United Kingdom, as it is an unlicensed medication that must not be marketed or distributed for human use under the Human Medicines Regulations 2012.
Some content creators attempt to circumvent the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and supply can still breach medicines, advertising, and customer laws, potentially leading to penalties, legal action or prison.
Service Reaction and Material Elimination
According to TikTok, the platform has removed problematic material and prohibited related keywords and search suggestions. The organization stated it was dedicated to maintaining the platform secure and investing in strengthening enforcement strategies.
Online Trading Activities
Research also found groups with up to 9,000 members marketing the experimental drug using Telegram's integrated discovery tool, which functions like a online catalog. Entering “retatrutide” immediately brings up groups with numerous of members, populated with photos of weight loss, glowing reviews and detailed instructions for preparing or administering at home.
After moments of entering one community, a seller posted contact information, where the majority of transactions occur. The vendor provided an instruction manual and guaranteed delivery within two days. When questioned whether the product was authentic, one seller said: “You can’t be sure.” Another provided a image of a alleged testing documentation. None inquired about body mass, health issues or previous experience.
Product Information and Costs
Inside these communities, posts show black plastic packages with postal service stickers, claiming to include new batches. One communication read: “It took eight of us to load them this morning.”
Buyers can choose between powder vials, prepared at home with purified liquid, or ready-to-use injectors typically sold at 160 pounds for 20 milligrams. When questioned how long a pen should be used, sellers give contradictory answers ranging from a few weeks to “depends on your body”.
Service Moderation and Security Measures
A representative for Telegram stated it regularly moderated dangerous content on its platform including material that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Medical Expert Cautions
“People are injecting materials they cannot confirm. Even if the science behind this drug is sound, these online versions may not contain what they advertise,” stated Jason Murphy, the director of pharmacy at Chemist4U.
A medical professional of Asda Online Doctor connected the surge in interest to recent price rises for authorized slimming drugs such as Mounjaro. “With prices increasing, individuals are using online platforms. But counterfeit treatments are highly dangerous. You cannot know what’s inside or whether the conditions they were produced in was sterile,” she said.
Her staff has already seen individuals injured by self-injection from unverified suppliers. “We recognize the disappointment, but buying from Telegram or communication platforms is gambling with your health,” stated the doctor. “These substances could be contaminated or improperly measured.”
Producer Position
A spokesperson from Eli Lilly stated retatrutide was in phase 3 research studies and had not been evaluated or approved by any regulatory agency globally. “Consequently at this point no one can sell [it] for personal consumption,” they explained, noting that any product “misleadingly claiming itself as a company investigational substance not yet authorized … may subject patients to potentially serious health risks”.
